[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ataibeckley Inc (ATAI)

Ataibeckley Inc (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,519,036
  • Shares Outstanding, K 366,917
  • Annual Sales, $ 4,090 K
  • Annual Income, $ -660,050 K
  • EBIT $ -74 M
  • EBITDA $ -102 M
  • 60-Month Beta 1.59
  • Price/Sales 373.29
  • Price/Cash Flow N/A
  • Price/Book 6.26

Options Overview Details

View History
  • Implied Volatility 87.64% (-5.72%)
  • Historical Volatility 72.02%
  • IV Percentile 12%
  • IV Rank 14.59%
  • IV High 176.51% on 05/09/25
  • IV Low 72.46% on 12/18/25
  • Expected Move (DTE 11) 0.55 (13.09%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 757
  • Volume Avg (30-Day) 4,200
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 89,007
  • Open Int (30-Day) 68,852
  • Expected Range 3.67 to 4.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.11
  • Number of Estimates 3
  • High Estimate $-0.08
  • Low Estimate $-0.15
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +26.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.57 +17.95%
on 04/13/26
5.51 -23.68%
on 04/20/26
+0.41 (+10.95%)
since 04/02/26
3-Month
3.27 +28.79%
on 03/24/26
5.51 -23.68%
on 04/20/26
+0.60 (+16.48%)
since 02/04/26
52-Week
1.29 +225.97%
on 05/08/25
6.75 -37.70%
on 10/20/25
+2.70 (+180.33%)
since 05/02/25

Most Recent Stories

More News
These 3 Psychedelic Stocks Activated After Trump's Executive Order

Psychedelic drugs could get a big boost thanks to a recent executive order, and these firms all have promising candidates in line.

CMPS : 9.51 (+5.55%)
PSIL : 20.17 (+0.20%)
ATAI : 4.21 (+1.69%)
DFTX : 21.88 (+0.83%)
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by...

ATAI : 4.21 (+1.69%)
Save This Psychedelic Stock Watchlist After Trump’s Latest Executive Order

From manufacturers to high volatility biotechs, these are the mind-bending med stocks our Senior Market Strategist is watching now.

CMPS : 9.51 (+5.55%)
PSIL : 20.17 (+0.20%)
ATAI : 4.21 (+1.69%)
JAZZ : 207.35 (+2.28%)
PBM : 6.20 (-0.80%)
This 4/20, Wall Street Is Betting on More Than Marijuana

Wall Street is currently pivoting toward high-growth biotech plays as federal support accelerates a revolution in alternative medicine.

IIPR : 53.11 (-2.53%)
CMPS : 9.51 (+5.55%)
CURLF : 3.2700 (-3.54%)
ATAI : 4.21 (+1.69%)
MSOS : 4.81 (-4.56%)
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026

2026 could be a pivotal year for three biotech names, including a standout in the hemodialysis space and two emerging companies with strong pipelines.

EVMN : 23.72 (-3.18%)
ATAI : 4.21 (+1.69%)
CRMD : 7.92 (+1.67%)
The 1 Riskiest Investment That Paid Off in 2025

Wall Street still sees triple-digit upside in this high-risk biotech bet.

ATAI : 4.21 (+1.69%)
$SPX : 7,199.27 (-0.43%)
Enhanced Fortifies Executive Leadership Team & Board of Directors

– Co-Founder Maximilian Martin Appointed CEO –

ATAI : 4.21 (+1.69%)
North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now.

As policy meets potential in North Carolina, Atai Life Sciences could be a solid portfolio addition now.

ATAI : 4.21 (+1.69%)
JNJ : 224.11 (-1.36%)
ATAI Life Sciences to Acquire Beckley Psytech

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ATAI Life...

ATAI : 4.21 (+1.69%)
Brera Holdings (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI

Brera Holdings (NASDAQ: BREA), which is rebranding as Solmate and pivoting to a Solana-based digital asset treasury and crypto infrastructure, surged after Cathie Wood’s ARK Invest purchased 6,500,001...

ROKU : 126.11 (+2.05%)
BREA : 25.20 (+1.94%)
AVAV : 181.57 (-1.84%)
ATAI : 4.21 (+1.69%)
BIDU : 128.16 (+1.81%)
ARCT : 8.56 (-0.81%)
PONY : 10.40 (+5.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing mental health treatments. The company's pipeline of novel therapies includes BPL-003 for treatment-resistant depression, VLS-01 for TRD and EMP-01 for social anxiety disorder. AtaiBeckley Inc., formerly known as Atai Beckley...

See More

Key Turning Points

3rd Resistance Point 4.31
2nd Resistance Point 4.25
1st Resistance Point 4.20
Last Price 4.21
1st Support Level 4.09
2nd Support Level 4.03
3rd Support Level 3.97

See More

52-Week High 6.75
Fibonacci 61.8% 4.66
Last Price 4.21
Fibonacci 50% 4.02
Fibonacci 38.2% 3.38
52-Week Low 1.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.